News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Inverness Medical Innovations, Inc. (IMA) and Biosite Incorporated (BSTE) Announce Expiration of Hart-Scott-Rodino Waiting Period



6/7/2007 12:58:53 PM

WALTHAM, Mass. and SAN DIEGO--(BUSINESS WIRE)--Inverness Medical Innovations, Inc. (Amex: IMA) and Biosite Incorporated (Nasdaq: BSTE) today announced that the waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 with respect to Inverness’ proposed acquisition of Biosite pursuant to a cash tender offer of $92.50 per share has expired without a request for additional information.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES